Liver fibrosis progression in hepatitis C virus infection after seroconversion.

ABSTRACT:

Importance

Knowing the rate of liver fibrosis progression in hepatitis C virus (HCV)-infected persons can help inform patients and providers (clinicians, medical institutions or organizations, and third-party payers) in making treatment decisions.

Objective

To determine the rate and factors associated with liver fibrosis progression and hepatic decompensation in persons after acquiring HCV infection.

Design, setting, and participants

Secondary data analysis of persons in the Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES), a national Veterans Affairs (VA) database, between 2002 and 2012. Among 610 514 persons in ERCHIVES (half were HCV positive), we identified those with an initial negative and subsequent positive test result for HCV antibody and p

SUBMITTER: Butt AA 

PROVIDER: S-EPMC5017246 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature